Now entering its second decade, the Marble Center for Cancer Nanomedicine develops nano-scale technologies and materials for cancer detection, treatment and monitoring.
Thursday, April 9, 2026, 4:30 - 6 p.m.
Koch Institute at MIT
500 Main Street, Building 76
Cambridge, MA 02139
The Marble Center for Cancer Nanomedicine is turning 10! Since 2016, the Marble Center has been leveraging advances in miniaturization to tackle grand challenges in cancer detection, treatment and monitoring. Join us as we celebrate Center research, highlight successes, and preview developments guiding the future of cancer nanomedicine.
Speakers include Marble Center director Sangeeta Bhatia and Koch Institute director Matthew Vander Heiden, Center member Bob Langer, and a panel of Center alumni and collaborators bringing nanomedicine applications to the market.
Refreshments to follow
Featuring
Sangeeta Bhatia, MD, PhD
Director, Marble Center for Cancer Nanomedicine
John J. and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science
Robert Langer, ScD
Member, Marble Center for Cancer Nanomedicine
David H. Koch (1962) Institute Professor
Matthew Vander Heiden, MD, PhD
Director, Koch Institute
Lester Wolfe (1919) Professor of Molecular Biology
Panelists
Susan Hockfield, PhD
President Emerita, MIT
Professor of Neuroscience
Moderator
Carmen Martin Alonso, PhD
Founding Scientist, Amplifyer Bio
Peter DeMuth, PhD
Chief Scientific Officer, Elicio Therapeutics
Vadim Dudkin, PhD
Founding Chief Technology Officer, Soufflé Therapeutics
Noor Jailkhani, PhD
CEO, Co-founder & President, Matrisome Bio